← Eichor
Condition: Injection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Injection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency
Phase 4 · 1 location(s) · Prove pharm · NCT06054880Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Phase 3 · 2 location(s) · Shanghai Yizhong Pharmaceutical Co., Ltd. · NCT06752811Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04778839PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors
Phase 1 · 1 location(s) · Shenzhen Celconta Life Science Co., Ltd. · NCT06897228Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+
Phase 1 · 1 location(s) · China Medical University, China · NCT06013111To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464This a Clinical Trial to Evaluate the Efficacy of I-PRF, Povidone-Iodine and Laser as Adjuncts to Non-surgical Periodont
Phase 4 · 1 location(s) · Military Hospital of Tunis · NCT07707063A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or R
Phase 3 · 1 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT07452198A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and
Phase 3 · 9 location(s) · Biocells (Beijing) Biotech Co.,Ltd · NCT07520565A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear S
Phase 3 · 1 location(s) · Huahui Health · NCT07499544Spine Bone Cements Outcomes - Post Market Follow-up
Phase N/A · 12 location(s) · Teknimed · NCT06367582USG-Guided Shoulder Injections in Frozen Shoulder
NA · 1 location(s) · Konya Beyhekim Training and Research Hospital · NCT07493213A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injectio
Phase 1 · 65 location(s) · GlaxoSmithKline · NCT06431594Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Tr
Phase 2 · 1 location(s) · Dai, Guanghai · NCT07392346Intralesional Versus Perilesional 5% Dextrose Injection in Partial Rotator Cuff Tears
NA · 1 location(s) · Ankara City Hospital Bilkent · NCT07688902Effect of TXA on Reducing Bruising After Filler Injection
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06665594Hypercalcemia After Paraffin Oil Injection
Phase N/A · 1 location(s) · Martin Blomberg Jensen · NCT04292288Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia
NA · 1 location(s) · ShangHai Ji Ai Genetics & IVF Institute · NCT06561451Comparison of Interlaminar CT Guided Epidural Platelet Rich Plasma Versus Steroid Injection in Patients With Lumbar Radi
NA · 1 location(s) · Clinique du Sport, Bordeaux Mérignac · NCT07036445A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection
Phase 2 · 39 location(s) · TG Therapeutics, Inc. · NCT07503873A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
Phase 2 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07299422Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial
Phase 4 · 3 location(s) · University of Witwatersrand, South Africa · NCT06485154An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treatin
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07101705A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scar
Phase 3 · 10 location(s) · AbbVie · NCT07207369A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizuma
Phase 2/Phase 3 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT07554456The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
Phase 4 · 1 location(s) · First Affiliated Hospital of Wannan Medical College · NCT06898723Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With R
NA · 1 location(s) · Beijing Boren Hospital · NCT06983951A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants
Phase 1/Phase 2 · 1 location(s) · TenNor Therapeutics Inc. · NCT06889701A Bioequivalence Study of PP3M in Patients With Schizophrenia
NA · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07493551
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.